<DOC>
	<DOCNO>NCT02986503</DOCNO>
	<brief_summary>The study first step process establish standard chemotherapy treatment aim improve outcome patient rare tumour . For reason study non-controlled clinical trial . In regard , study aim determine feasibility intensive chemotherapy age group , and/or separate efficacy analyse accord different histologic category whether number patient recruit co-operating group permit future randomise study .</brief_summary>
	<brief_title>European Study Bone Sarcoma Patients Over 40 Years</brief_title>
	<detailed_description>Wide surgical removal tumor addition systemic treatment base antineoplastic drug active osteosarcoma ( Adriamycin , Cisplatin , Ifosfamide , Methotrexate ) . The use radiation therapy give patient unresectable tumor . It recommend patient underwent inadequate surgical removal tumor . The addition radiation therapy compensate adequate surgical treatment . All patient eligible study receive plan systemic treatment . Depending clinical feature , feasibility adequate surgical removal tumor , patient may receive primary chemotherapy follow postoperative chemotherapy treatment adjuvant chemotherapy . In case immediate surgery , patient receive adjuvant treatment 3-drug regimen ( Cisplatin-Adriamycin-Ifosfamide ) .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>1 . Histologically proven diagnosis highgrade sarcoma bone site . 2 . Histologic type : osteosarcoma ( highgrade surface , central primary secondary ) , fibrosarcoma , malignant fibrous histiocytoma , leiomyosarcoma , dedifferentiate chondrosarcoma , angiosarcoma . 3 . Age : 41 65 4 . Normal bone marrow , hepatic , cardiac renal function 5 . Absence contraindication use cisplatin , adriamycin , ifosfamide 6 . Written inform consent 1 . Planned chemotherapy and/or followup feasible 2 . Previous chemotherapy treatment , contraindicate use one drug , include present protocol 3 . Previous chemotherapy treatment current tumor 4 . White blood count &lt; 3.0 x 109/L , platelet &lt; 100 x 109/L 5 . Creatinine clearance &lt; 70 ml/min 6 . Left ventricular ejection fraction &lt; 55 % fractional shortening rate leave ventricle &lt; 28 % 7 . Serum transaminases bilirubin &gt; 2 time normal value 8 . ECOG performance status &gt; 2 9 . Chondrosarcoma small/round cell bone sarcoma include mesenchymal chondrosarcoma Ewing 's family tumor .</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>